Global Label-free Array Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Label-free Array Systems Market is presumed to reach the market size of nearly USD 10.85 BN by 2030 from USD 4.74 BN in 2022 with a CAGR of 9.64% under the study period 2023 - 2030.

Label-free array system refers to the biotechnological identification technology extensively used to study molecular interaction. It is based on the identification of various molecules depending on the biophysical properties to correctly isolate the molecular presence. Surface plasmon resonance (SPR) is the generally used technique for label-free arrey systems. It provides multiple benefits such as quick delivery, dependability, reliability and accuracy etc. It does not need any radioactive or fluorescent labels, tags or specialized agents in the preparation of assay. It is less expensive along with providing a high level of information.

MARKET DYNAMICS:

The key factor driving the demand for label-free array system market is the increasing demand for advanced systems to achieve productive drug discovery processes. Growing demand for atomic force microscopy (AFM) and its use as a high-resolution tool to study ultrastructure and mechanical characteristics of tumour cells are surging the demand for this market. In addition, the increase in demand for microcantilevers in clinical applications is propelling the demand for this market. The growing pharmaceutical and biotechnology companies are expanding the need for this market. Furthermore, continuous advancement in technology, rise in R&D investments and growth in the healthcare sector are augmenting the demand for this market. However, the high cost associated with the instruments of this technology may hinder the growth of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of label-free array systems. The growth and trends of label-free array systems industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the label-free array systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technique

Surface Plasmon Resonance
Microcantilever
Scanning Kelvin Nanoprobe
Enthalpy Array
Atomic Force Microscopy
Electrochemical Impedance Spectroscopy
Interference-Based Technique
Ellipsometry Technique

By Application

Drug Discovery
Biomolecular Interactions
Detection Of Disease Biomarkers
Others

By End-User

Contract Research Organizations
Academic & Research Institutes
Pharmaceutical & Biotechnology Industries
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Label-free Array Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the label-free array systems market include GE Healthcare, Attana AB, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, GWC Technologies, PerkinElmer, Inc., and BiOptix, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219406

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . LABEL-FREE ARRAY SYSTEMS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technique
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET ANALYSIS BY TECHNIQUE

6.1 Overview by Technique
6.2 Historical and Forecast Data
6.3 Analysis by Technique
6.4 Surface Plasmon Resonance Historic and Forecast Sales by Regions
6.5 Microcantilever Historic and Forecast Sales by Regions
6.6 Scanning Kelvin Nanoprobe Historic and Forecast Sales by Regions
6.7 Enthalpy Array Historic and Forecast Sales by Regions
6.8 Atomic Force Microscopy Historic and Forecast Sales by Regions
6.9 Electrochemical Impedance Spectroscopy Historic and Forecast Sales by Regions
6.10. Interference-based Technique Historic and Forecast Sales by Regions
6.11 Ellipsometry Technique Historic and Forecast Sales by Regions

7 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Drug Discovery Historic and Forecast Sales by Regions
7.5 Biomolecular Interactions Historic and Forecast Sales by Regions
7.6 Detection Of Disease Biomarkers Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Contract Research Organizations Historic and Forecast Sales by Regions
8.5 Academic & Research Institutes Historic and Forecast Sales by Regions
8.6 Pharmaceutical & Biotechnology Industries Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL LABEL-FREE ARRAY SYSTEMS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE LABEL-FREE ARRAY SYSTEMS COMPANIES

10.1. Label-Free Array Systems Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF LABEL-FREE ARRAY SYSTEMS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. GE Healthcare
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Attana AB
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Agilent Technologies Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Danaher Corporation
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. F. Hoffmann-La Roche AG
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Bio-Rad Laboratories
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. GWC Technologies
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. PerkinElmer Inc.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. BiOptix Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies